EIGER BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 28249U955. A total of 2 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 200 | -91.7% | 0.00% | – |
Q1 2023 | $2 | 0.0% | 2,400 | +33.3% | 0.00% | – |
Q4 2022 | $2 | -100.0% | 1,800 | -57.1% | 0.00% | – |
Q3 2022 | $31,000 | +3000.0% | 4,200 | +2000.0% | 0.00% | – |
Q2 2022 | $1,000 | -97.7% | 200 | -96.3% | 0.00% | – |
Q1 2022 | $44,000 | -65.1% | 5,400 | -62.8% | 0.00% | – |
Q3 2021 | $126,000 | +2.4% | 14,500 | 0.0% | 0.00% | – |
Q2 2021 | $123,000 | +123.6% | 14,500 | +22915.9% | 0.00% | – |
Q1 2021 | $55,000 | +400.0% | 63 | +600.0% | 0.00% | – |
Q4 2020 | $11,000 | +37.5% | 9 | -10.0% | 0.00% | – |
Q3 2020 | $8,000 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 200 | $0 | 0.00% |